Small Molecule vs. Peptide Separation: What's Different?

In the second episode of this LCGC International Peer Exchange®, the panel explores what analytical scientists with a small-molecule background can expect when they begin working with GLP-1 peptides. Nitish Sharma leads the response by contrasting the separation logic of the two molecule classes. Small-molecule reverse-phase separations, he explains, are governed primarily by partition between the stationary and mobile phases, with mobile-phase pH typically selected 1.5 to 2 units from the analyte's pKa. Peptides behave differently: their higher molecular weight means separation is influenced more by diffusion, and method development must account for the peptide's isoelectric point (pI) rather than pKa alone, since small shifts in organic solvent concentration can produce outsized changes in retention time. Sharma also outlines the three chromatographic modes most commonly used to resolve peptide impurities from the active compound—reverse-phase (RP), ion-exchange (IEC), and size-exclusion chromatography (SEC)—each suited to a different impurity type.

Piotr Alvarez builds on this by describing just how crowded a GLP-1 impurity profile can become. Because these peptide agonists can be manufactured through either purely synthetic or biosynthetic routes, each processing step—synthesis, purification, or otherwise—has the potential to introduce a distinct impurity. The result, he notes, can be 10 to 20 or more closely related peaks with highly similar physicochemical properties, compounded further by isomers and stereoisomers that are often difficult to resolve by liquid chromatography (LC) and can appear identical by mass spectrometry (MS). Alvarez emphasizes that untangling this complexity typically requires complementary or orthogonal separation mechanisms paired with more advanced detection systems.

Together, the panelists establish the foundational challenge that shapes the rest of the discussion: peptide separation science demands a different analytical mindset than small-molecule work, from method parameters down to how impurities are even conceptualized.